vs
Gogo Inc.（GOGO）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Gogo Inc.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.1倍（$230.6M vs $207.3M），Gogo Inc.净利率更高（-4.3% vs -62.0%，领先57.7%），Gogo Inc.同比增速更快（67.3% vs 25.9%），Gogo Inc.自由现金流更多（$-25.4M vs $-100.8M），过去两年Gogo Inc.的营收复合增速更高（48.7% vs 38.0%）
Gogo Inc.是美国公务机机载宽带互联网及连接服务提供商，总部位于科罗拉多州布鲁姆菲尔德。截至目前，已有超过2500架商用飞机和6600架公务机安装了该公司的机载Wi-Fi服务。该公司曾面向民航业提供机上WiFi服务，2020年12月已将这块民航业务以4亿美元出售给国际通信卫星组织。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
GOGO vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $230.6M | $207.3M |
| 净利润 | $-10.0M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 6.2% | -54.7% |
| 净利率 | -4.3% | -62.0% |
| 营收同比 | 67.3% | 25.9% |
| 净利润同比 | 64.6% | 3.5% |
| 每股收益（稀释后） | $-0.08 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $230.6M | $207.3M | ||
| Q3 25 | $223.6M | $159.9M | ||
| Q2 25 | $226.0M | $166.5M | ||
| Q1 25 | $230.3M | $139.3M | ||
| Q4 24 | $137.8M | $164.6M | ||
| Q3 24 | $100.5M | $139.5M | ||
| Q2 24 | $102.1M | $147.0M | ||
| Q1 24 | $104.3M | $108.8M |
| Q4 25 | $-10.0M | $-128.6M | ||
| Q3 25 | $-1.9M | $-180.4M | ||
| Q2 25 | $12.8M | $-115.0M | ||
| Q1 25 | $12.0M | $-151.1M | ||
| Q4 24 | $-28.2M | $-133.2M | ||
| Q3 24 | $10.6M | $-133.5M | ||
| Q2 24 | $839.0K | $-131.6M | ||
| Q1 24 | $30.5M | $-170.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 87.8% | — | ||
| Q1 25 | 87.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 6.2% | -54.7% | ||
| Q3 25 | 12.9% | -106.9% | ||
| Q2 25 | 15.9% | -64.8% | ||
| Q1 25 | 15.3% | -102.6% | ||
| Q4 24 | -17.5% | -74.3% | ||
| Q3 24 | 19.0% | -94.6% | ||
| Q2 24 | 21.2% | -79.1% | ||
| Q1 24 | 33.2% | -151.9% |
| Q4 25 | -4.3% | -62.0% | ||
| Q3 25 | -0.9% | -112.8% | ||
| Q2 25 | 5.7% | -69.0% | ||
| Q1 25 | 5.2% | -108.5% | ||
| Q4 24 | -20.5% | -80.9% | ||
| Q3 24 | 10.6% | -95.7% | ||
| Q2 24 | 0.8% | -89.5% | ||
| Q1 24 | 29.2% | -156.8% |
| Q4 25 | $-0.08 | $-1.28 | ||
| Q3 25 | $-0.01 | $-1.81 | ||
| Q2 25 | $0.09 | $-1.17 | ||
| Q1 25 | $0.09 | $-1.57 | ||
| Q4 24 | $-0.22 | $-1.34 | ||
| Q3 24 | $0.08 | $-1.40 | ||
| Q2 24 | $0.01 | $-1.52 | ||
| Q1 24 | $0.23 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $125.2M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $101.1M | $-80.0M |
| 总资产 | $1.3B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $125.2M | $421.0M | ||
| Q3 25 | $133.6M | $202.5M | ||
| Q2 25 | $102.1M | $176.3M | ||
| Q1 25 | $70.3M | $127.1M | ||
| Q4 24 | $41.8M | $174.0M | ||
| Q3 24 | $176.7M | $150.6M | ||
| Q2 24 | $161.6M | $480.7M | ||
| Q1 24 | $152.8M | $112.3M |
| Q4 25 | $101.1M | $-80.0M | ||
| Q3 25 | $107.0M | $9.2M | ||
| Q2 25 | $102.8M | $151.3M | ||
| Q1 25 | $82.9M | $144.2M | ||
| Q4 24 | $69.3M | $255.0M | ||
| Q3 24 | $52.7M | $346.8M | ||
| Q2 24 | $52.0M | $432.4M | ||
| Q1 24 | $62.4M | $140.3M |
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.3B | $1.3B | ||
| Q1 25 | $1.2B | $1.3B | ||
| Q4 24 | $1.2B | $1.5B | ||
| Q3 24 | $810.7M | $1.5B | ||
| Q2 24 | $802.7M | $1.6B | ||
| Q1 24 | $809.0M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.5M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-25.4M | $-100.8M |
| 自由现金流率自由现金流/营收 | -11.0% | -48.6% |
| 资本支出强度资本支出/营收 | 14.7% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $65.1M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $8.5M | $-99.8M | ||
| Q3 25 | $46.8M | $-91.4M | ||
| Q2 25 | $36.7M | $-108.3M | ||
| Q1 25 | $32.5M | $-166.5M | ||
| Q4 24 | $-38.3M | $-79.3M | ||
| Q3 24 | $25.1M | $-67.0M | ||
| Q2 24 | $24.9M | $-77.0M | ||
| Q1 24 | $29.7M | $-190.7M |
| Q4 25 | $-25.4M | $-100.8M | ||
| Q3 25 | $27.3M | $-92.7M | ||
| Q2 25 | $33.5M | $-110.7M | ||
| Q1 25 | $29.7M | $-167.8M | ||
| Q4 24 | $-42.6M | $-79.5M | ||
| Q3 24 | $20.7M | $-68.6M | ||
| Q2 24 | $21.6M | $-79.0M | ||
| Q1 24 | $28.2M | $-193.9M |
| Q4 25 | -11.0% | -48.6% | ||
| Q3 25 | 12.2% | -58.0% | ||
| Q2 25 | 14.8% | -66.5% | ||
| Q1 25 | 12.9% | -120.5% | ||
| Q4 24 | -30.9% | -48.3% | ||
| Q3 24 | 20.6% | -49.2% | ||
| Q2 24 | 21.1% | -53.7% | ||
| Q1 24 | 27.0% | -178.2% |
| Q4 25 | 14.7% | 0.5% | ||
| Q3 25 | 8.7% | 0.8% | ||
| Q2 25 | 1.4% | 1.5% | ||
| Q1 25 | 1.2% | 1.0% | ||
| Q4 24 | 3.1% | 0.1% | ||
| Q3 24 | 4.4% | 1.2% | ||
| Q2 24 | 3.3% | 1.4% | ||
| Q1 24 | 1.4% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.87× | — | ||
| Q1 25 | 2.70× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.36× | — | ||
| Q2 24 | 29.74× | — | ||
| Q1 24 | 0.97× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GOGO
| Services | $191.9M | 83% |
| Products | $38.7M | 17% |
| Fcc Reimbursement Program | $2.0M | 1% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
